2024 Prohibited List

The new list comes into force on 1 January 2024.

The 2024 Prohibited List of Substances and Methods comes into force on 1 January 2024.

The World Anti-Doping Agency (WADA) has published the:

2024 Prohibited List of Substances and Methods

Summary of major modifications and explanatory notes

2024 Monitoring Program

An update on changes to the List will be included in Sport Integrity Australia’s 2024 Annual Update course for athletes and support personnel.

 

Education course Annual Update 2024 banner

 

Major changes in 2024

S7. Narcotics 

Tramadol, sold under various brand names including Tramal, Tramedo and Zydol, is a prescription medicine used for short-term pain relief. Tramadol is already banned in-competition in cycling, and in 2024 it will be banned in-competition for all athletes.  

M1. Manipulation of blood and blood components

Plasma donation by plasmapheresis performed in a registered collection centre is now permitted and does not require a Therapeutic Use Exemption (TUE) as of 1 January 2024. Previously, plasmapheresis was prohibited under M1. Manipulation of Blood and Blood Components because blood components are removed and then reintroduced to the circulatory system. However, donation by athletes of plasma or plasma components by plasmapheresis by an official registered blood donation facility is no longer prohibited.

New wash-out period for rectal glucocorticoids

Athletes who need to use glucocorticoids by the rectal route of administration out-of-competition can now follow the published guidelines to know when to stop using them in advance of a competition, or to figure out the time window when a TUE application may be necessary.

 

Monitoring program

The Monitoring Program includes substances that are not on the Prohibited List, but WADA wishes to monitor to detect patterns of misuse in sport.

The following substances are placed on the 2024 Monitoring Program:

Anabolic agents

In- and Out-of-Competition: Ecdysterone.

Peptides Hormones, Growth Factors, Related Substances, and Mimetics

In- and Out-of-Competition: Gonadotrophin-releasing hormone (GnRH) analogues in females under 18 years only.

Hypoxen (polyhydroxyphenylene thiosulfonate sodium)

In- and Out-of-Competition.

Stimulants

In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol and synephrine.

Narcotics

In-Competition only: Codeine, dermorphin (and its analogues), dihydrocodeine, hydrocodone and tapentadol.

Semaglutide

In- and Out-of-Competition.